Last $0.14 USD
Change Today 0.00 / 0.00%
Volume 0.0
ORXE On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 05/16/13 All times are local (Market data is delayed by at least 15 minutes).

ore holdings inc (ORXE) Snapshot

Open
$0.14
Previous Close
$0.14
Day High
$0.14
Day Low
$0.14
52 Week High
06/21/12 - $0.34
52 Week Low
04/24/13 - $0.11
Market Cap
738.9K
Average Volume 10 Days
500.0
EPS TTM
$-0.71
Shares Outstanding
5.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ORE HOLDINGS INC (ORXE)

Related News

No related news articles were found.

ore holdings inc (ORXE) Related Businessweek News

No Related Businessweek News Found

ore holdings inc (ORXE) Details

Ore Holdings, Inc. focuses on developing and monetizing pharmaceutical assets, including clinical-stage compounds in-licensed from pharmaceutical companies. Its drug candidate portfolio includes ORE1001, an orally-administered small molecule drug for treating inflammatory bowel disease and other gastrointestinal indications; ORE10002, a small molecule serotonergic agent for inflammatory and autoimmune diseases; tiapamil, a small molecule L-type calcium channel antagonist to treat cardiovascular disease, various cognitive disorders, and gastrointestinal indications; and romazarit, a small molecule PPARá agonist for autoimmune, metabolic, inflammatory, and gastrointestinal diseases. The company was formerly known as Ore Pharmaceutical Holdings Inc. and changed its name to Ore Holdings, Inc. in June 2011. Ore Holdings, Inc. was founded in 1994 and is based in Cambridge, Massachusetts.

ore holdings inc (ORXE) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

ore holdings inc (ORXE) Key Developments

Ore Holdings, Inc Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2011

Ore Holdings Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2011. For the quarter, the company reported loss from operations of $248,000 against $239,000 a year ago. Net loss was $353,000 or $0.04 per basic and diluted share against $237,000 or $0.04 per basic and diluted share a year ago. There was no revenue for the three month periods ended September 30, 2011 and September 30, 2010. For the nine months, the company reported loss from operations of $2,089,000 against $2,330,000 a year ago. Net loss was $2,432,000 or $0.28 per basic and diluted share against $2,307,000 or $0.42 per basic and diluted share a year ago. There was no revenue for the nine month periods ended September 30, 2011 and September 30, 2010.

Ore Holdings, Inc Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2011

Ore Holdings Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2011. For the quarter, the company reported net loss of $1,006,000 or $0.12 per basic and diluted share compared to net loss of $956,000 or $0.17 per basic and diluted share reported a year ago. Loss from operations was $893,000 compared to $968,000 for the same period of last year. For the six months, the company reported net loss of $2,078,000 or $0.24 per basic and diluted share compared to net loss of $2,070,000 or $0.38 per basic and diluted share reported a year ago. Loss from operations was $1,840,000 compared to $2,091,000 for the same period of last year.

Ore Holdings, Inc will Change its Ticker to ORXE from ORXE.D

Effective July 13, 2011, Ore Holdings, Inc will change its OTCPK stock ticker symbol to ORXE from ORXE.D.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ORXE:US $0.14 USD 0.00

ORXE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ORXE.
View Industry Companies
 

Industry Analysis

ORXE

Industry Average

Valuation ORXE Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORE HOLDINGS INC, please visit www.orepharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.